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Leaves ofStevia rebaudiana Bertoni have been popularly used as a sweetener in foods and beverages for
diabetics and obese people due to their potent sweetener stevioside. In this report, stevioside and steviol were
tested for mutagenicity inSalmonella typhimurium strains TA98 and TA100 and for chromosomal effects on
cultured human lymphocytes. Stevioside was not mutagenic at concentrations up to 25 mg/plate, but showed
directmutagenicitytoonlyTA98at50mg/plate.However,stevioldidnotexhibitmutagenicityineitherTA98or
TA100, with or without metabolic activation. No significant chromosomal effect ofstevioside and steviol was
observed in cultured bloodlymphocytes from healthydonors (n = 5). This study indicates that stevioside and
steviol areneithermutagenic norclastogenicin vitro atthelimiteddoses; however,in vivo genotoxictests and
long-term effects ofstevioside and steviol are yet to be investigated.
Introduction
SteviarebaudianaBertoniis asmallherb(Compositae)
(Fig. 1). Theplantis native to SouthAmerica and hasbeen
used for sweetening beverages and foods since 1600 (1).
Stevia became popular and commercialized by Japanese.
Theplanthasbeendistributed tosoutheastAsiaincluding
Thailand [as "Ya wan" (2)]. More than 750 tons of stevia
leavesperyearareused ascrude extractforconsumption.
The sweetening compound was isolated from stevialeaves
by Rebaudi and Resenac (3), and was named as "ste-
vioside" (4,5). Stevioside has very high sweetening
potency, 250-300 times that of sucrose, but little caloric
value (6). Its sweetness is stable to heatandyeastfermen-
tation. Stevia and stevioside have been applied as a sugar
substitute and used by those with obesity, diabetes
mellitus, heart disease, and dental caries (7). Stevioside
can also inhibit the growth ofcertain bacteria (8).
Eight different sweetening ent-kaurene glycosides
(from about 88 compounds in stevia leaves) were isolated
(9). The common alycone of those glycosides is steviol,
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chemically ent-13-hydroxy kaur-16-en-19-oic acid. As
shown in Figure 2, stevioside is the main sweetglycoside,
6-8%, in dry stevia leaves (10).
FIGURE 1. Stevia rebaudiana Bertoni.SUTTAJIT ETAL.
Toxicological Evaluation
The toxicological effects ofstevia extractand stevioside
have been pharmacologically and biochemically studied
(8,11-17) and reviewed (1,3,18). In experimentally induced
diabetic rabbits, stevioside can lower the level of blood
glucosetemporarily(16). Italsolessenedbradyeardia (16).
It has been shown that neither stevia extract nor ste-
vioside is toxic or teratogenic in mice, rats, hamsters, and
guineapigs byoral administration (11-17). However, acute
toxicity can be seen in experimental animals when fatal
dosesofstevioside areadministered IP orIV[LD50values
between 1 and >34g/kgbodyweight(1)].
Mutagenicity
The mutagenicity of crude stevia extract, stevioside,
and steviol have been reported (18-23). Stevioside showed
no mutagenicity in bacterial systems (18-20); however, its
aglycone, steviol, wasmutagenicaftermetabolicactivation
in the forward mutation assay using only Salmonella
typhimurium TA677 (TM677) (21) but not mutagenic in
the reversemutation testusingSalmmellkatyphimurium
TA100, TA98, TA102, or TA97. When steviol was meta-
bolically activated with S-9 from Aroclor 1254-pretreated
rats, 15-oxosteviol was found to be the mutagenic product
in the forward mutation assay (22). It was suggested (23)
that this major, oxidized steviol was responsible for the
indirect mutagenicity of steviol in TM677, probably by
selectively inducing a deletion or insertion of more than
one base pair, which cannot be found in strains of TA98,









FIGURE 2. Chemical structure ofstevioside.
Carcinogenicity
No evidence has been reported that stevioside and its
metabolites are carcinogenic. No carcinogenicity was
detected in hamsters given stevioside orally for 6 months
and in long-term feeding for 2 years in rats (1,17).
Contraceptive Activity and Teratogenicity
It was shown that 5% water decoction of stevia leaves
reduced the fertility of female rats by about 65% (24).
Stevioside (95-98% pure) had no effects on the rate of
pregnancy or the development of rat fetuses (25). Ste-
vioside did not cause any abnormalities on mating, preg-
nancy, or the development offetuses in the experimental
animals (15,26).




and there is no report of any plant toxicity to the con-
sumers. The safety ofstevia crude extract and stevioside
have been well accepted and their various products com-
mercialized in Japan as sweeteners for several foodstuffs
(7,8). Stevialeaveshavebeenused asherbal teabymixing
withotherplantproducts forreducingsugarconsumption
in diabetic patients in Thailand (27). No side effects were
observed in these patients after 5 years of continued
consumption. Long-term genotoxicity and health risks in
humans have not been completely assessed. In Thailand,
stevia leaves or their crude extract have been legally
permitted to be used commercially as a herbal teaby the
Ministry of Public Health, but purified stevioside as an
additive in foods and drinks has not yet been legalized.
However, stevioside has been permitted to be exported.
More evidence of the safety ofproducts from stevia and
stevioside and health risk assessment on their genotox-
icity are needed. In this report, the mutagenicity and
human-chromosomal effect of stevioside and its aglycone
steviol were tested and considered for further health risk
assessment.
Materials and Methods
TestedCompounds. Steviosidewasisolated from stevia
leaves byhot-water extraction, decolorized by electrolysis
andion-exchangechromatography,andcrystallizedbythe
methodpreviouslyreported(29).Thepurityoftheproduct
was 99%. Steviol was obtained by periodate oxidation of
stevioside, followed byacid hydrolysis and crystallization.
Mutagenicity Assay The Salmonella mutation with
preincubation was assayed using S-9 mix prepared from
the livers of rats pretreated with sodium phenobarbital
and 5,6-benzoflavone as previously described (30). The
tester strains were Salmnella typhimurium TA98 and
TA100. Thebacteriawere culturedin Oxoidnutrientbroth
no. 2-14 hr before each assay. The histidine+ revertants
were scored. All samples analyzed were in duplicate.
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Chromosomal Aberration Test. Whole-blood samples
from five healthy donors were used. Lymphocyte cultures
were performed according to the standard method. After
24 hrofincubation, thecultureswereaddedwith different
concentrations ofstevioside (1, 5, and10mg/mL) orsteviol
(0.1 and 0.2 mg/mL). Mitomycin C at 1 p,g/mL was used.
Structural chromosomes aberrations were analyzed from




the presence or absence of S-9 mix, stevioside was not
mutagenic toward Salnwnella typhimurium TA98. How-
ever, at the higher dose, 50 mg/mL, stevioside showed
significant mutagenicity (four times the control) ofTA98
without metabolic activation, while the same dose demon-
strated a slight increase of bacterial mutation with the
addition ofS-9mix. Underthe same doses and conditions,
stevioside did not exhibit any mutagenic activity toward
TA100.
The spontaneous revertants were between 30 and 151
per plate. Two positive controls were done using 2-ami-
noanthracene (2-AA), 0.5 ,ug/plate, + S-9 mix and 2-(2-
furyl)-3-nitro-2-furyl)acrylamide (AF-2), 0.1 ,ug/plate, S-9
mix. The former gave 789revertants forTA98 and 997 for
TA100andthelatteryielded666mutantsforTA98and604
for TA100.
Steviol, 1-20 mg/plate, did not show mutagenic activity
to either TA98 or TA100. Higher doses ofsteviol were not
tested due to their strong cytotoxicity to both tester
strains. The treatment with I8-glucosidase on 50 mg ste-
vioside did not significantly alter its mutagenic effect to
TA98 either with or without metabolic activation (Fig. 3).
Chromosomal Aberrations
Stevioside at concentrations of 1, 5, and 10 mg/mL did
not cause any significant aberrations ofmetaphasic chro-
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FIGURE 3. Reversion ofS. typhimurium TA98 by stevioside.
mosomesinallbloodsamplesanalyzed(p > 0.05).Similarly,
steviolat0.1 and0.2mg/mL didnotshowanysignificantly
abnormal change ofchromosomes in four blood samples,
except in one case. Steviol (0.1 and 0.2 mg/mL) in the
presenceofS-9mixinonetestedbloodsampledidnotalter
theresult. However,underthesameconditions,mitomycin
as thepositive control causedremarkable genetic damage
ofchromosomes.
Discussion
We have shown the lack of mutagenicity of stevioside
and steviol at limited doses (up to 20 mg) toward Salmo-
nellatyphimuriumstrainsTA98andTA100with orwith-
out metabolic activation. This confirmed the findings
previously reported (18,21) that crude stevia extract and
stevioside were negative toward TA98 and TA100 muta-
tion. By using other various systems such as reversion
mutation (18), bacterial recombination (19), host-mediated
mutation (20), Salmonellamutation (22), forward mutation
(21), chromosome aberration on human fetus fibroblasts
(8), and dominant lethality (8), all the mentioned muta-
genicity invitro were negativebothwith andwithout S-9
mix. Pimbua et al. (21) also demonstrated that stevioside
wasnotmutagenic, evenafterincubatingwithmicrosomal
enzymaticfractionsfromliversofdifferentanimalspecies.
Generally, stevioside per se is not a mutagen toward
bacterial cells oragenotoxinto culturedmammaliancells,
and it is not carcinogenic to experimental animals either.
Only at an unusually high dose, 50 mg/plate, was ste-
vioside mutagenic to TA98 but not to TA100. The muta-
genicity might be due to some impurities in the sample.
Crude extractofstevialeaveswas shownbyotherinvesti-
gators to have some slight mutagenicity to TA100 (8) and
induce weak chromosomal aberration in fibroblasts from
Chinese hamsters (20). The mutagenic activity of ste-
viosideatthehighdosewasmoreevidentintheabsenceof
itsmetabolic activationthanwithS-9mix.Thedecrease of
mutagenicity by the presence ofS-9 mix might be due to
someinactivation ofsuchhighamountofsteviosideduring
the preincubation with rat-liver microsomal enzymes. If
impurities were notresponsible, stevioside seemedtobe a
veryweak, direct-acting mutagen.
Steviol was shown to be nonmutagenic in TA98 and
TA100bythereversemutationassay. Inseveralmutagenic
assays, only one forward mutation assay reported by
Perzzuto et al. (20) and Pimbua et al. (21) with steviol at 5
mg/plate was shown to be mutagenic toward Salmonella
typhimurium TA677 eitherwith orwithout S-9 mix. The
15-oxosteviolwasreportedtobeanactivemetabolitefrom
steviolincubatedwithratliverS-9mix,anditwasshownto
be a direct-acting mutagen toward Salmonella typhi-
muriumTM677(23).Noinvitrocarcinogenicityofsteviol
hasbeenstudied.Thehealthriskoflong-termingestionof
stevioside has to be studied further. Experimentally, ste-
vioside was converted into steviol by hydrolysis of
endogenous or bacterial enzyme(s) in rats orally given
with 3H-stevioside (31). Steviol and dihydrosteviol could
inhibit the mitochondrial translocation of adenine
nucleotides and also inhibit energy metabolism, oxygen
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consumption, andgluconeogenesis (32). Itis stillunknown
whethersteviolcouldbeformedduringingestion andthen
absorbed in human gastrointestinal tract.
Itwasconcludedthatstevioside and steviol, atlessthan
20 mg/plate, are not mutagenic toward Salmonella
typhimurium strains TA98 and TA100 with or without
metabolic activation. At higher concentrations, stevioside
showedweakmutagenicitytoTA98,whichmightbedueto
contamination by impurities. An in vitro chromosomal
effect on human lymphocytes ofstevioside and steviolwas
notobserved. However, otherinvitro genotoxicitystudies
on stevioside and its metabolites and their long-term
consumption in humans are yet to be investigated.
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